Project Grant K01HL171819
Award Date
4/10/25
Completion Date
3/31/30
Dollars Obligated
$168K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60611, USA
Similar Awards
This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research Program (CFDA 93.837), supports a 5-year, $126,059 research project conducted by the University of Colorado-Denver. The project aims to utilize proximity extension assay technology to perform longitudinal proteomic analyses of children with congenital heart disease (CHD) in order to identify novel biomarkers and understand the systems biology underlying...
This $2,087,677 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), supports research to investigate how the chromatin remodeling factor CHD7 regulates the development of cardiac and craniofacial lymphatic vessels. The primary grantee, Children's Hospital Los Angeles, will perform confocal and live imaging, lineage tracing, single-cell multiomics analysis, spatial transcriptomics, and...
This federal Project Grant award, valued at $1,399,182.00 and awarded by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) on August 1, 2024, supports a comprehensive research study to investigate early-life risk factors and underlying mechanisms for the development of adult coronary heart disease (CHD). The primary objectives are to: 1) identify which small-for-gestational-age (SGA) infants are at elevated risk for later-life CHD and cardiovascular...
This federal Project Grant award of $2,251,975.00, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to identify unrecognized genetic causes of congenital heart disease (CHD). The award supports research with the following key objectives: Assessing the contribution of de novo non-coding variants of unknown significance (NCDNV) to unexplained CHD cases. Defining the contribution of rare coding region variants...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Program (CFDA 93.837), will provide $198,936 to New York University School of Medicine to investigate the impact of restrictive drug coverage policies on heart failure care. The key products and services to be delivered through this 5-year grant include: Quantifying the effects of restrictive drug coverage policies, such as cost-sharing and prior authorization...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $163,080 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Ann & Robert H Lurie Children's Hospital of Chicago. The grant, which runs from September 1, 2024 to August 31, 2029, will fund research to understand the age-specific mechanisms that promote recovery from severe viral pneumonia in children. Specifically, the project will examine whether juvenile regulatory T cells have impaired...
This Project Grant award, with a total funding amount of $1,276,293, was provided by the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837). The award aims to develop a new clinical decision support (CDS) tool for early detection of cardiopulmonary deterioration events in hospitalized children. The key objectives are to: 1) Derive and validate a hospital-wide cardiopulmonary deterioration prediction model using...
This $161,175 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support a multi-year research study led by Dr. Jonathan Edelson at The Children's Hospital of Philadelphia (CHOP). The overarching goal is to develop a better understanding of the environmental determinants of physical activity in pediatric heart transplant patients, a population at high risk of cardiovascular complications. The...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $487,567 to Indiana University to conduct integrative genomic analysis and develop high-dimensional risk prediction models for congenital heart defects (CHDs). The research aims to identify genetic variants and biological pathways associated with CHDs, as well as build predictive models leveraging genetic, epigenetic,...
The National Heart, Lung, and Blood Institute (NHLBI), through the Cardiovascular Diseases Research federal grant program (CFDA 93.837), awarded the Icahn School of Medicine at Mount Sinai (ISMMS) a $777,954 Project Grant to conduct a mixed-method study focused on identifying school policy interventions to improve adolescent cardiovascular health and reduce racial/ethnic disparities in maternal health outcomes. The study will construct a school-based adolescent preconception cohort, engage...